151 related articles for article (PubMed ID: 21237643)
1. Selective antagonists of mouse trace amine-associated receptor 1 (mTAAR1): discovery of EPPTB (RO5212773).
Stalder H; Hoener MC; Norcross RD
Bioorg Med Chem Lett; 2011 Feb; 21(4):1227-31. PubMed ID: 21237643
[TBL] [Abstract][Full Text] [Related]
2. The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system.
Bradaia A; Trube G; Stalder H; Norcross RD; Ozmen L; Wettstein JG; Pinard A; Buchy D; Gassmann M; Hoener MC; Bettler B
Proc Natl Acad Sci U S A; 2009 Nov; 106(47):20081-6. PubMed ID: 19892733
[TBL] [Abstract][Full Text] [Related]
3. The TAAR1 inhibitor EPPTB suppresses neuronal excitability and seizure activity in mice.
Kong Q; Zhang H; Wang M; Zhang J; Zhang Y
Brain Res Bull; 2021 Jun; 171():142-149. PubMed ID: 33811954
[TBL] [Abstract][Full Text] [Related]
4. Pyrrolidin-3-yl-N-methylbenzamides as potent histamine 3 receptor antagonists.
Zhou D; Gross JL; Sze JY; Adedoyin AB; Bowlby M; Di L; Platt BJ; Zhang G; Brandon N; Comery TA; Robichaud AJ
Bioorg Med Chem Lett; 2011 Oct; 21(19):5957-60. PubMed ID: 21843941
[TBL] [Abstract][Full Text] [Related]
5. N-(3-Ethoxy-phenyl)-4-pyrrolidin-1-yl-3-trifluoromethyl-benzamide (EPPTB) prevents 3-iodothyronamine (T1AM)-induced neuroprotection against kainic acid toxicity.
Landucci E; Gencarelli M; Mazzantini C; Laurino A; Pellegrini-Giampietro DE; Raimondi L
Neurochem Int; 2019 Oct; 129():104460. PubMed ID: 31075293
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.
Fish PV; Wakenhut F; Ryckmans T; Stobie A
Bioorg Med Chem Lett; 2009 Aug; 19(16):4579-83. PubMed ID: 19616432
[TBL] [Abstract][Full Text] [Related]
7. Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors.
Leo D; Mus L; Espinoza S; Hoener MC; Sotnikova TD; Gainetdinov RR
Neuropharmacology; 2014 Jun; 81():283-91. PubMed ID: 24565640
[TBL] [Abstract][Full Text] [Related]
8. Discovery of aminobenzyloxyarylamides as κ opioid receptor selective antagonists: application to preclinical development of a κ opioid receptor antagonist receptor occupancy tracer.
Mitch CH; Quimby SJ; Diaz N; Pedregal C; de la Torre MG; Jimenez A; Shi Q; Canada EJ; Kahl SD; Statnick MA; McKinzie DL; Benesh DR; Rash KS; Barth VN
J Med Chem; 2011 Dec; 54(23):8000-12. PubMed ID: 21958337
[TBL] [Abstract][Full Text] [Related]
9. Ractopamine, a livestock feed additive, is a full agonist at trace amine-associated receptor 1.
Liu X; Grandy DK; Janowsky A
J Pharmacol Exp Ther; 2014 Jul; 350(1):124-9. PubMed ID: 24799633
[TBL] [Abstract][Full Text] [Related]
10. Aminoalkoxybenzyl pyrrolidines as novel human urotensin-II receptor antagonists.
Jin J; Dhanak D; Knight SD; Widdowson K; Aiyar N; Naselsky D; Sarau HM; Foley JJ; Schmidt DB; Bennett CD; Wang B; Warren GL; Moore ML; Keenan RM; Rivero RA; Douglas SA
Bioorg Med Chem Lett; 2005 Jul; 15(13):3229-32. PubMed ID: 15936190
[TBL] [Abstract][Full Text] [Related]
11. Discovery of 8-azabicyclo[3.2.1]octan-3-yloxy-benzamides as selective antagonists of the kappa opioid receptor. Part 1.
Brugel TA; Smith RW; Balestra M; Becker C; Daniels T; Hoerter TN; Koether GM; Throner SR; Panko LM; Folmer JJ; Cacciola J; Hunter AM; Liu R; Edwards PD; Brown DG; Gordon J; Ledonne NC; Pietras M; Schroeder P; Sygowski LA; Hirata LT; Zacco A; Peters MF
Bioorg Med Chem Lett; 2010 Oct; 20(19):5847-52. PubMed ID: 20727752
[TBL] [Abstract][Full Text] [Related]
12. Interaction analyses of hTAAR1 and mTAAR1 with antagonist EPPTB.
Liao S; Pino MJ; Deleon C; Lindner-Jackson M; Wu C
Life Sci; 2022 Jul; 300():120553. PubMed ID: 35452636
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization, and biological assessment of the four stereoisomers of the H(3) receptor antagonist 5-fluoro-2-methyl-N-[2-methyl-4-(2-methyl[1,3']bipyrrolidinyl-1'-yl)phenyl]benzamide.
Gao Z; Hurst WJ; Guillot E; Nagorny R; Pruniaux MP; Hendrix JA; George PG
Bioorg Med Chem Lett; 2013 Jul; 23(14):4044-7. PubMed ID: 23769643
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of novel histamine H4 receptor antagonists.
Lane CA; Hay D; Mowbray CE; Paradowski M; Selby MD; Swain NA; Williams DH
Bioorg Med Chem Lett; 2012 Jan; 22(2):1156-9. PubMed ID: 22189138
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a series of 2-phenyl-N-(2-(pyrrolidin-1-yl)phenyl)acetamides as novel molecular switches that modulate modes of K(v)7.2 (KCNQ2) channel pharmacology: identification of (S)-2-phenyl-N-(2-(pyrrolidin-1-yl)phenyl)butanamide (ML252) as a potent, brain penetrant K(v)7.2 channel inhibitor.
Cheung YY; Yu H; Xu K; Zou B; Wu M; McManus OB; Li M; Lindsley CW; Hopkins CR
J Med Chem; 2012 Aug; 55(15):6975-9. PubMed ID: 22793372
[TBL] [Abstract][Full Text] [Related]
16. 2-(Pyrrolidin-1-yl)ethyl-3,4-dihydroisoquinolin-1(2H)-one derivatives as potent and selective histamine-3 receptor antagonists.
Zhou D; Gross JL; Adedoyin AB; Aschmies SB; Brennan J; Bowlby M; Di L; Kubek K; Platt BJ; Wang Z; Zhang G; Brandon N; Comery TA; Robichaud AJ
J Med Chem; 2012 Mar; 55(5):2452-68. PubMed ID: 22313242
[TBL] [Abstract][Full Text] [Related]
17. 1-(4-Amino-phenyl)-pyrrolidin-3-yl-amine and 6-(3-amino-pyrrolidin-1-yl)-pyridin-3-yl-amine derivatives as melanin-concentrating hormone receptor-1 antagonists.
Huang CQ; Baker T; Schwarz D; Fan J; Heise CE; Zhang M; Goodfellow VS; Markison S; Gogas KR; Chen T; Wang XC; Zhu YF
Bioorg Med Chem Lett; 2005 Aug; 15(16):3701-6. PubMed ID: 16005225
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of novel benzamide derivatives as potent smoothened antagonists.
Wu TM; Wang DC; Xiang P; Zhang JN; Sang YX; Lin HJ; Chen J; Xie G; Song H; Zhao YL; Xie YM
Bioorg Med Chem Lett; 2014 Mar; 24(5):1426-31. PubMed ID: 24491459
[TBL] [Abstract][Full Text] [Related]
19. Further insights into the pharmacology of the human trace amine-associated receptors: discovery of novel ligands for TAAR1 by a virtual screening approach.
Cichero E; Espinoza S; Franchini S; Guariento S; Brasili L; Gainetdinov RR; Fossa P
Chem Biol Drug Des; 2014 Dec; 84(6):712-20. PubMed ID: 24894156
[TBL] [Abstract][Full Text] [Related]
20. Discovery and structure-activity relationships of urea derivatives as potent and novel CCR3 antagonists.
Nitta A; Iura Y; Tomioka H; Sato I; Morihira K; Kubota H; Morokata T; Takeuchi M; Ohta M; Tsukamoto S; Imaoka T; Takahashi T
Bioorg Med Chem Lett; 2012 Aug; 22(15):4951-4. PubMed ID: 22749826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
